Search This Blog

Wednesday, December 29, 2021

Orchard Therapeutics resumed at Overweight by Cantor

 Target to $9 from $12

https://finviz.com/quote.ashx?t=ortx&ty=c&ta=1&p=d

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)